FareWell and the How of Lifestyle Medicine.

Autor:	Berman MA; FareWell, Inc, San Francisco, California (MAB, KJA, KLE, DLK).; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts (DME).; Yale University Prevention Research Center, Griffin Hospital, Derby, CT (DLK)., Appelbaum KJ; FareWell, Inc, San Francisco, California (MAB, KJA, KLE, DLK).; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts (DME).; Yale University Prevention Research Center, Griffin Hospital, Derby, CT (DLK)., Edwards KL; FareWell, Inc, San Francisco, California (MAB, KJA, KLE, DLK).; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts (DME).; Yale University Prevention Research Center, Griffin Hospital, Derby, CT (DLK)., Eisenberg DM; FareWell, Inc, San Francisco, California (MAB, KJA, KLE, DLK).; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts (DME).; Yale University Prevention Research Center, Griffin Hospital, Derby, CT (DLK)., Katz DL; FareWell, Inc, San Francisco, California (MAB, KJA, KLE, DLK).; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts (DME).; Yale University Prevention Research Center, Griffin Hospital, Derby, CT (DLK).
Jazyk:	angličtina
Zdroj:	American journal of lifestyle medicine [Am J Lifestyle Med] 2017 Apr 06; Vol. 11 (4), pp. 314-317. Date of Electronic Publication: 2017 Apr 06 (Print Publication: 2017).
DOI:	10.1177/1559827617701411
Abstrakt:	The what of Lifestyle Medicine, including a whole foods dietary pattern, has been well established, but the how has remained elusive. How do we apply what we know in a cost-effective and widely accessible manner to prevent, treat, and even reverse chronic disease? Over the decade ahead, we believe the field of Lifestyle Medicine and the people who need it most will benefit from addressing the how. This article summarizes the founding and operational principles of FareWell Inc. - a digital therapeutics company targeting lifestyle-related cardiometabolic diseases. We outline our current use of mobile health technology and artificial intelligence and describe our early clinical experience, business model, and key anticipated challenges. Competing Interests: Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu